When apoptosis meets autophagy: deciding cell fate after trauma and sepsis

Trends in Molecular Medicine

Volumn 15, Issue 3, 2009, Pages 129-138

  Hsieh, Ya Ching ^a   Athar, Mohammad ^b   Chaudry, Irshad H ^c  

^a I SHOU UNIVERSITY   (Taiwan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BCL 2;

APOPTOSIS; AUTOPHAGY; BLEEDING; CELL DIFFERENTIATION; CELL FATE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MITOCHONDRION; REVIEW; SEPSIS;

ANIMALS; APOPTOSIS; AUTOPHAGY; HEART; HEMORRHAGE; HUMANS; SEPSIS; WOUNDS AND INJURIES;

EID: 61849140067     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2009.01.002     Document Type: Review

References (89)

1. Smith J.W., et al. Immunologic responses to critical injury and sepsis. J. Intensive Care Med. 21 (2006) 160-172
2. Brunn G.J., and Platt J.L. The etiology of sepsis: turned inside out. Trends Mol. Med. 12 (2006) 10-16
3. Ulloa L., and Tracey K.J. The 'cytokine profile': a code for sepsis. Trends Mol. Med. 11 (2005) 56-63
4. Venet F., et al. Regulatory T cell populations in sepsis and trauma. J. Leukoc. Biol. 83 (2008) 523-535
5. Hotchkiss R.S., and Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6 (2006) 813-822
6. Hotchkiss R.S., et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166 (2001) 6952-6963
7. Tinsley K.W., et al. Caspases-2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 13 (2000) 1-7
8. Wesche D.E., et al. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol. 78 (2005) 325-337
9. Carlson D.L., et al. Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit. Care Med. 33 (2005) 1021-1028
10. Hsieh Y.C., et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-β is critical for inhibiting mitochondrial apoptotic signalling and restoring cardiac functions following trauma-hemorrhage. J. Mol. Cell. Cardiol. 41 (2006) 511-521
11. Wang M., et al. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H221-H226
12. Levine B., and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132 (2008) 27-42
13. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8 (2001) 569-581
14. Levine B., and Yuan J. Autophagy in cell death: an innocent convict?. J. Clin. Invest. 115 (2005) 2679-2688
15. Hamacher-Brady A., et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14 (2007) 146-157
16. Yan L., et al. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13807-13812
17. Ravikumar B., et al. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15 (2006) 1209-1216
18. Colell A., et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129 (2007) 983-997
19. Scott R.C., et al. Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr. Biol. 17 (2007) 1-11
20. Mizushima N., et al. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
21. Xu Y., et al. Autophagy contributes to caspase-independent macrophage cell death. J. Biol. Chem. 281 (2006) 19179-19187
22. Chen Y., et al. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 15 (2008) 171-182
23. Hamacher-Brady A., et al. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281 (2006) 29776-29787
24. Schlottmann S., et al. Prolonged classical NF-κB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation. Mediators Inflamm. 2008 (2008) 725854
25. Levine B., and Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7 (2007) 767-777
26. Ohtani M., et al. mTOR and GSK3 differentially regulate LPS-induced IL-12 production in dendritic cells. Blood 112 (2008) 635-643
27. Dos Santos S., et al. Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-κB and PI3K/mTOR signaling pathways. Ann. N. Y. Acad. Sci. 1096 (2007) 70-77
28. Bommhardt U., et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 172 (2004) 7583-7591
29. Hotchkiss R.S., et al. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J. Immunol. 174 (2005) 5110-5118
30. Hostmann A., et al. Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mcl-1 proteins. Crit. Care 12 (2008) R8
31. + T lymphocyte apoptosis and modulates the balance of Th1 and Th2 responses in the rat with traumatic hemorrhagic shock. Shock 30 (2008) 692-698
32. Qin S., et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203 (2006) 1637-1642
33. Taneja R., et al. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit. Care Med. 32 (2004) 1460-1469
34. Hsieh Y.C., et al. Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage. Am. J. Physiol. Lung Cell. Mol. Physiol. 292 (2007) L1227-L1232
35. Buerke U., et al. Apoptosis contributes to septic cardiomyopathy and is improved by Simvastatin therapy. Shock 29 (2008) 497-503
36. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defence. Cell 120 (2005) 159-162
37. Schmid D., and Munz C. Innate and adaptive immunity through autophagy. Immunity 27 (2007) 11-21
38. Hotchkiss R.S., et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168 (2002) 2493-2500
39. Kawasaki T., et al. Trauma-hemorrhage induces depressed splenic dendritic cell functions in mice. J. Immunol. 177 (2006) 4514-4520
40. Brazil M.I., et al. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur. J. Immunol. 27 (1997) 1506-1514
41. Schmid D., et al. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26 (2007) 79-92
42. Pua H.H., et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 204 (2007) 25-31
43. Subauste C.S., et al. CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 3 (2007) 245-248
44. Djavaheri-Mergny M., et al. NF-κB activation represses tumor necrosis factor-α-induced autophagy. J. Biol. Chem. 281 (2006) 30373-30382
45. Wright K., et al. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem. 272 (1997) 12626-12633
46. Hsieh Y.C., et al. Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage. J. Cell. Physiol. 211 (2007) 364-370
47. Mollen K.P., et al. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26 (2006) 430-437
48. Xu Y., et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27 (2007) 135-144
49. Qu X., et al. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128 (2007) 931-946
50. Terman A., and Brunk U.T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc. Res. 68 (2005) 355-365
51. Martinet W., et al. Autophagy in cardiovascular disease. Trends Mol. Med. 13 (2007) 482-491
52. Sybers H.D., et al. Autophagy in cardiac myocytes. Recent Adv. Stud. Cardiac Struct. Metab. 12 (1976) 453-463
53. Decker R.S., and Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am. J. Pathol. 98 (1980) 425-444
54. Valentim L., et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J. Mol. Cell. Cardiol. 40 (2006) 846-852
55. Matsui Y., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100 (2007) 914-922
56. Saeki K., et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ. 7 (2000) 1263-1269
57. Shimizu S., et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6 (2004) 1221-1228
58. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005) 927-939
59. Furuya N., et al. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1 (2005) 46-52
60. Levine B., et al. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4 (2008) 600-606
61. Ferraro E., and Cecconi F. Autophagic and apoptotic response to stress signals in mammalian cells. Arch. Biochem. Biophys. 462 (2007) 210-219
62. Abedin M.J., et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 14 (2007) 500-510
63. Tsujimoto Y., and Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ. 12 Suppl 2 (2005) 1528-1534
64. Brealey D., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
65. Cauwels A., et al. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4 (2003) 387-393
66. Tasdemir E., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10 (2008) 676-687
67. Cheng Y., et al. ERK and JNK mediate TNFα-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem. Biophys. Res. Commun. 376 (2008) 483-488
68. Hotchkiss R.S., et al. p53-dependent and -independent pathways of apoptotic cell death in sepsis. J. Immunol. 164 (2000) 3675-3680
69. Shi C.S., and Kehrl J.H. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J. Biol. Chem. 283 (2008) 33175-33182
70. Hotchkiss R.S., et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162 (1999) 4148-4156
71. Daubeuf B., et al. TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J. Immunol. 179 (2007) 6107-6114
72. Hsieh Y.C., et al. 17β-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Mol. Immunol. 44 (2007) 2165-2172
73. Bosshart H., and Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann. N. Y. Acad. Sci. 1096 (2007) 1-17
74. Leon C.G., et al. Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm. Res. 25 (2008) 1751-1761
75. Hotchkiss R.S., et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14541-14546
76. Mauriz J.L., et al. Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock 19 (2003) 33-37
77. Davidson M.T., et al. Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms. Ann. Surg. 240 (2004) 123-131
78. Chun H.J., et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419 (2002) 395-399
79. White E. Autophagic cell death unravelled: pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 4 (2008) 399-401
80. Yu L., et al. Regulation of an ATG7-Beclin 1 program of autophagic cell death by caspase-8. Science 304 (2004) 1500-1502
81. Wu Y.T., et al. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 4 (2008) 457-466
82. Bell B.D., et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16677-16682
83. Karantza-Wadsworth V., et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 21 (2007) 1621-1635
84. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006) 51-64
85. Kim K.W., et al. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4 (2008) 659-668
86. Galluzzi L., et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 14 (2007) 1237-1243
87. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 (2008) 151-175
88. Kroemer G., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16 (2009) 3-11
89. Kroemer G., and Levine B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9 (2008) 1004-1010